共 50 条
- [1] Ipilimumab/nivolumabAutoimmune encephalitis: case report [J]. Reactions Weekly, 2019, 1771 (1) : 177 - 177
- [2] Ipilimumab/nivolumabAutoimmune pneumonitis: case report [J]. Reactions Weekly, 2023, 1950 (1) : 229 - 229
- [3] Ipilimumab/nivolumabAutoimmune hepatitis: case report [J]. Reactions Weekly, 2022, 1889 (1) : 182 - 182
- [4] Ipilimumab/nivolumabAutoimmune encephalitis: case report [J]. Reactions Weekly, 2021, 1866 (1) : 225 - 225
- [5] Ipilimumab/nivolumabAutoimmune encephalitis: case report [J]. Reactions Weekly, 2019, 1778 (1) : 258 - 258
- [6] Ipilimumab/nivolumabAutoimmune encephalitis: case report [J]. Reactions Weekly, 2022, 1902 (1) : 253 - 253
- [7] Ipilimumab/nivolumabAutoimmune hepatitis: case report [J]. Reactions Weekly, 2022, 1910 (1) : 266 - 266
- [8] Ipilimumab/nivolumabAutoimmune adrenalitis: case report [J]. Reactions Weekly, 2022, 1929 (1) : 358 - 358
- [9] Ipilimumab/nivolumabAutoimmune hepatitis: case report [J]. Reactions Weekly, 2019, 1752 (1) : 218 - 218
- [10] Ipilimumab/nivolumabAutoimmune encephalitis: case report [J]. Reactions Weekly, 2021, 1847 (1) : 257 - 257